Technical Analysis for JAGX - Jaguar Animal Health, Inc.

Grade Last Price % Change Price Change
grade F 0.1919 -9.91% -0.02
JAGX closed down 9.91 percent on Monday, May 20, 2019, on 49 percent of normal volume.

Earnings due: May 21

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical JAGX trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Wide Bands Range Expansion 0.00%
Bullish Engulfing Bullish -9.91%
Crossed Above 20 DMA Bullish -9.91%
Pocket Pivot Bullish Swing Setup -9.91%
Wide Range Bar Range Expansion -9.91%
Outside Day Range Expansion -9.91%
Wide Bands Range Expansion -9.91%
Oversold Stochastic Weakness -9.91%

Older signals for JAGX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Jaguar Animal Health, Inc., a development-stage animal health company, focuses on developing and commercializing gastrointestinal products for companion and production animals. The company's lead prescription drug product candidate includes Canalevia, a canine-specific formulation of Crofelemer for the treatment of CID and general acute watery diarrhea in dogs. It is also developing Crofelemer to treat acute colitis in horses and general acute watery diarrhea in cats; Neonorm, an enteric-coated tablet for scours in preweaned dairy calves, as well as other animal species, such as horses, goats, and sheep; and other product candidates, including Virend and NP-500. The company was founded in 2013 and is headquartered in San Francisco, California. Jaguar Animal Health, Inc. is a subsidiary of Napo Pharmaceuticals, Inc.
Medicine Medical Specialties Gastroenterology Diarrhea Salix Pharmaceuticals Gastrointestinal Products Gastrointestinal Tract
Is JAGX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.2
52 Week Low 0.115
Average Volume 9,621,034
200-Day Moving Average 0.4307
50-Day Moving Average 0.2436
20-Day Moving Average 0.2042
10-Day Moving Average 0.1868
Average True Range 0.0254
ADX 16.53
+DI 24.7948
-DI 19.7566
Chandelier Exit (Long, 3 ATRs ) 0.1738
Chandelier Exit (Short, 3 ATRs ) 0.2412
Upper Bollinger Band 0.2465
Lower Bollinger Band 0.1619
Percent B (%b) 0.35
BandWidth 41.429971
MACD Line -0.017
MACD Signal Line -0.0177
MACD Histogram 0.0008
Fundamentals Value
Market Cap 20.76 Million
Num Shares 108 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -1.23
Price-to-Sales 11.19
Price-to-Book 0.00
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.25
Resistance 3 (R3) 0.25 0.24 0.24
Resistance 2 (R2) 0.24 0.22 0.23 0.24
Resistance 1 (R1) 0.21 0.21 0.21 0.21 0.23
Pivot Point 0.20 0.20 0.19 0.20 0.20
Support 1 (S1) 0.18 0.18 0.17 0.17 0.15
Support 2 (S2) 0.16 0.17 0.16 0.15
Support 3 (S3) 0.14 0.16 0.14
Support 4 (S4) 0.13